...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Number of shares to compute the price per share

According to latest MD&A 125.6 mm shares, 132.5 mm fully diluted as of sept 25/17

Share
New Message
Please login to post a reply